Skip to main content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Transforming the understanding
and treatment of mental illnesses.

Molecular Imaging Branch (MIB)

2022 Publications

Full Refereed Papers

A. Boyle, A. Navarez, J. Tong, S.S. Zoghbi, V.W. Pike, R.B. Innis, N. Vasdev, Repurposing [11C]MC1 for PET imaging of cyclooxygenase-2 in colorectal cancer xenograft mouse models. Mol. Imag. Biol. (2022) 24, 366-370. DOI:10.1007/s11307-021-01675-0. https://pubmed.ncbi.nlm.nih.gov/34766247/ 

J.-H. Lee, F.G. Siméon, J.-S. Liow, C. L. Morse, R.L. Gladding, J.A. Montero Santamaria, I.D. Henter, S.S. Zoghbi, V.W. Pike, R.B. Innis, In vivo evaluation of six analogs of 11C-ER176 as candidate 18F-labeled radioligands for translocator protein 18 kDa (TSPO). J. Nucl. Med. (2022) 63, 1252-1258. DOI:10.2967/jnumed.121.263168. https://pubmed.ncbi.nlm.nih.gov/35027372/ 

K. Smart, M.-Q. Zheng, H. Ahmed, H. Fang, Y. Xu, L. Cai, D. Holden, M. Kapinos, Z. Felchner, J.R. Ropchan, G. Tamagnan, R.B. Innis, V.W. Pike, S.M. Ametamey, Y. Huang, R.E. Carson, Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in vivo in non-human primates: (R)-[11C]-NR2B-Me, (R)-[18F]-OF-Me-NB1, and (S)-[18F]-OF-NB1. J. Cereb. Blood Flow Metab. (2022) 42, 1398-1409. DOI:10.1177/0271678x221084416. https://pubmed.ncbi.nlm.nih.gov/35209743/ 

M. Viviano, E. Barresi, F.G. Siméon, B. Costa, S. Taliani, F. Da Settimo, V.W. Pike, S. Castellano, Essential principles and recent progress in the development of TSPO PET ligands for neuroinflammation imaging. Curr. Med. Chem. (2022) 29, 4862-4890. DOI:10.2174/0929867329666220329204054https://pubmed.ncbi.nlm.nih.gov/35352645/ 

Y. Wakabayashi, P. Stenkrona, R. Arakawa, X. Yan, M.G. Van Buskirk, M.D. Jenkins, J.A. Montero Santamaria, K.P. Maresca, A. Takano, J.S. Liow, T.A. Chappie, A. Varrone, S. Nag, L. Zhang, Z.A. Hughes, C.J. Schmidt, S.D. Doran, A. Mannes, P. Zanotti-Fregonara, M. Ooms, C. L. Morse, S.S. Zoghbi, C. Halldin, V.W. Pike, R.B. Innis, First-in-human evaluation of 18F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B. J. Nucl. Med. (2022) 63, 1919-1924. DOI:10.2967/jnumed.122.263838. https://pubmed.ncbi.nlm.nih.gov/35772961/ 

H.U. Shetty, C.L. Morse, V.W. Pike, Tandem mass spectrometry as an independent method for corroborating fluorine-18 radioactivity measurements in positron emission tomography. ACS Measurement Science Au. (2022) 2, 370-376. DOI:10.1021/acsmeasuresciau.2c00018. https://pubmed.ncbi.nlm.nih.gov/35996540/ 

B.V. Kenou, L.S. Manly, S.B. Rubovits, S.A. Umeozulu, M.G. Van Buskirk, A.S. Zhang, V.W. Pike, P. Zanotti-Fregonara, I.D. Henter, R. B. Innis, Cyclooxygenases as Potential PET Imaging Biomarkers to Explore Neuroinflammation in Dementia. J. Nucl. Med. (2022) 63, 53s-59s. DOI:10.2967/jnumed.121.263199. https://pubmed.ncbi.nlm.nih.gov/35649646/